January 9, 2023
Getting to the heart of chemotherapeutic cardiotoxicity
Brian Jensen, MD, sees cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.
January 9, 2023
Brian Jensen, MD, sees cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.
January 9, 2023
A multi-institutional national study has identified unique molecular features responsible for the development and progression of metastatic breast cancer.
January 5, 2023
Researchers report specific immune system cells can help them determine whether HER2-positive breast cancer will respond to treatment.
December 21, 2022
Jessica Thaxton, PhD, MsCR, and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
December 21, 2022
Join us as we reflect on stories from 2022 that inspired us throughout the year.
December 21, 2022
Hats for Hope brings homemade hats to the North Carolina Basnight Cancer Hospital in memory of 9-year-old Charli' Ramsey.
December 15, 2022
Walthall was 39 years old and had never smoked. No one suspected lung cancer, and she had no family history of the disease. But in February, she was diagnosed with stage 4 lung cancer.
December 15, 2022
Shakira Grant, MBBS, the studies’ principal investigator, shared the findings during oral presentations at the annual meeting of the American Society of Hematology (ASH) in New Orleans.
December 15, 2022
Lindsey James, PhD, is well-suited to the collaborative relationship between UNC Lineberger and UNC Eshelman School of Pharmacy, taking her interests in medicinal chemistry and epigenetics and working with cancer center physicians and researchers to make strides into cancer care and treatment.
December 15, 2022
A study led by UNC Lineberger's Shakira Grant, MBBS, and colleagues found several barriers to high-quality cancer care for people with multiple myeloma and their caregivers.